Correspondence to the editorial “ASB3 degrades the gateway to β-oxidation: on Hepatocytic ASB3 deficiency alleviates MASLD by decreasing ubiquitin-mediated CPT1A”
Dongqin Yang1, Yuli Lin2, Chunhua Song3, Ming Guan1
1Department of Laboratory Medicine and Central Laboratory of Huashan Hospital, Fudan University, Shanghai 200040, China 2Department of Immunology, School of Basic Medical Sciences, Shanghai Medical College, Fudan University, Shanghai 200032, China 3Division of Hematology, The Ohio State University Wexner Medical Center, the James Cancer Hospital, Columbus, OH 43210, USA
Corresponding author:
Ming Guan, Tel: 86-21-52889999, Email: guanming88@yahoo.com
Dongqin Yang and Yuli Lin contributed equally to this study as co-first authors.
Received: 25 September 2025 • Accepted: 27 September 2025
